Further, oncogenic signaling pathways including ERBB2/ERK/AKT, WNT/β-Catenin, JAK/STAT, ERα and NF-κB can reduce VDR levels, thereby reducing the tumor suppressive effect of VD [42]. The gene discussed is VDR; the disease is neoplasm.